Utilising Biomarkers to Eliminate Drug Candidates with Cardiotoxicity in Preclinical Development
Posted in Archive
| Tagged AI / data analytics / healthtech / informatics, Biochemistry, Biomarkers, Business, Cell therapy, Cellular & Molecular biology, Chemistry, Clinical trials, Drug development, Drug discovery, Drug targets, Enabling technologies, Gene editing, Gene therapy, Genetics / genomes, Genomics, High Content Screening, High throughput screening, Imaging, Lead discovery, Molecular medicine, Pathology, Preclinical, Protein chemistry / Proteomics, Regulatory, RNA, Screening, Target validation, Toxicology, Translational, Translational chemistry
